Progesterone Found To Increase Ovarian Cancer Risk ( A new genetic discovery could help give...)

Progesterone Found To Increase Ovarian Cancer Risk

A new genetic discovery could help give insight into a very deadly disease. Latest research shows two variations in the gene // that codes for the progesterone receptor increase a woman’s risk of ovarian cancer.

The PGR had previously been linked to a higher ovarian cancer risk as well as a lower breast cancer risk in women who carry it. Researchers used biological samples from an ongoing study and examined the variety of gene variations found in the PGR gene to see if there was an association with the risk for ovarian cancer in women.

While scientists say the PGR likely does play a role in the risk of ovarian cancer, they discovered something even more interesting. They found the greatest influence on ovarian cancer risk came from two variations of the gene. These two variations raised a woman’s ovarian cancer risk by nearly four-fold.

In conclusion researchers say they know progesterone appears to protect women from ovarian cancer, while increasing their risk of breast cancer and it was observed that changes in the progesterone receptor, which is what the progesterone hormone does, might decrease the receptor’s efficiency, reducing the influence on the body’s cell. This can lead to ovarian cancer. However, they say that more such studies should be done in the future to confirm this theor.

Page: 1
Related medicine news :

1. Serum Progesterone Helps Stratify Ectopic Pregnancy Risk
2. Fluoride Found Effective in Osteoporosis
3. Implantable Contact Lens Found Safe and Effective
4. Cancer hazard Found With Animal-Based Nutrients
5. Processed Meat, Diabetes connection Found
6. Night Time Aspirin Regimen Found to Reduce Blood Pressure
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
9. Preventive Therapies Found to be More Effective in Managing Migraines
10. Common Cold Found to Fight Cancer
11. Circumcision Found To Prevent HIV Spread

Post Your Comments:

(Date:12/2/2009)...NEAPOLIS, Dec. 3 The Am...C) has designated Hennepin Regional Poison Center ...control center - a major milestone for the center.... Regional Poison Center among 58 accredited poison...n represents a major accomplishment. It means we h...

(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker.c...available in its catalogue: ,, Kinase Inhibit...ker.com/p0166819/Kinase-Inhibitors-Global-Markets....viding data for the years 2005 through 2008, and p...th rates (CAGRs) through 2014 ,, An overview o...

(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker.co...vailable in its catalogue: ,, Antibiotic Resis... ,, http://www.reportlinker.com/p0166825/Antib...l-Markets.html ,, Provide an in-depth review o... antibiotics technologies ,, Offer an analysis ...

(Date:12/2/2009)... , BOSTON, Dec. 2 The Washingto...rises 8%. According to Coremetrics, a marketing o...ent on Cyber Monday compared to Cyber Monday 2008....a Sante Day Spas who reported today "Cyber Monday...t sales rose 59%" - said Tiffany Amorosino, COO of...

(Date:12/2/2009)...ng incidence of obesity could counter recent incre...(HealthDay News) -- The overall health of the U.S....es, largely because people have quit smoking in dr...oon be wiped out if the rising obesity rates among...t trends in both smoking and obesity continue unch...

[1] Hennepin Regional Poison Center Designated as an Accredited Poison Control Center [1] Reportlinker Adds Kinase Inhibitors: Global Markets [0] Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets [0] The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%.[0] Health Gains From Lowered Smoking Rates in Jeopardy

...Ohio New research suggests that certain small mol...make might also help doctors identify adult acute-... to therapy. , Researchers say the findings should...d the levels of molecules called microRNAs in leuk...

...onal antibody to chemo lowered toxicity, lengthene...Treatment that combines the monoclonal antibody ri...urvival in elderly patients with aggressive lympho...he February print issue of the journal. , Research...

...ions appear to be concentrating among the least ed...ns which saw higher levels of infection among the ...y in the journal AIDS. , A team led by Dr. James...ver time in sub-Saharan Africa. , HIV has spread...

...mediately Address FDA Ruling, TORONTO, Jan. 15 /P...,PreMD Inc. (TSX: PMD; Amex: PME) announced today ...t (NSE) letter from the U.S. Food and Drug,Adminis...o evaluate its options as part of the plans to add...

...R Store Gift of Mobility Answers Prayers of Disabl...d is Good!",declares Stephanie Richardson, age 56,...ties. Unable to stand or walk, and without any fam...ndependence were answered today when The SCOOTER S...

...n. 15 BeneChill, Inc., today announced it,has rec...inoChill System in,European Union member countries...-invasive, portable, and easy-to-use medical devic..." said Denise Barbut, MD, who,is founder and CEO o...

Other Medicine News:Health News:Molecules might identify high-risk acute-leukemia patients 2 Health News:Combo Treatment Best for Elderly Lymphoma Patients 2 Health News:HIV shifting from most to least educated in sub-Saharan Africa 2 Health News:PreMD Announces FDA Decision on POC Skin Cholesterol Test 2 Health News:PreMD Announces FDA Decision on POC Skin Cholesterol Test 3 Health News:Philadelphia Policeman Helps Amputee Receive Power Wheelchair from The Scooter Store 2 Health News:BeneChill's RhinoChill System Receives CE Marking for European Commercial Sale 2

Molecules might identify high-risk acute-leukemia patients Combo Treatment Best for Elderly Lymphoma Patients HIV shifting from most to least educated in sub-Saharan Africa PreMD Announces FDA Decision on POC Skin Cholesterol Test Philadelphia Policeman Helps Amputee Receive Power Wheelchair from The Scooter Store BeneChill's RhinoChill System Receives CE Marking for European Commercial Sale

(Date:12/2/2009)... , NEW YORK, Dec. 2 Report...port is available in its catalogue: ,, Chiral ... Trends ,, http://www.reportlinker.com/p01642...arket-Trends.html ,, The fast developing smal...a flurry of activity with pharmaceutical companies...

(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportl...ort is available in its catalogue: ,, Hepatiti...rket Trends & Opportunities ,, http://www...herapeutics---A-Global-Update-of-Market-Trends--Op...d for all these years of meager clinical outcomes ...

(Date:12/2/2009)... , LAS ANGELES, December 2 /PRNewswire-Fir...I) announced today that it would initiate a progra...em informed of the significant,progress which Foun...lan, as,well as to provide shareholders with regul...Dunn Capital Partners and others. , Fount...

Breaking Medicine Technology:Reportlinker Adds Chiral Technology - International Technology & Market Trends 2 Reportlinker Adds Chiral Technology - International Technology & Market Trends 3 Reportlinker Adds Chiral Technology - International Technology & Market Trends 4 Reportlinker Adds Chiral Technology - International Technology & Market Trends 5 Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 2 Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 3 Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 4 Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 5 Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 6 Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 7 Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities 8 Fountain Healthy Aging Inc Business Update For Shareholders 2 Fountain Healthy Aging Inc Business Update For Shareholders 3 Pharmacyclics Inc Rights Offering Oversubscribed 13381 1 Pharmacyclics Inc Rights Offering Oversubscribed 13381 2 Pharmacyclics Inc Rights Offering Oversubscribed 13381 3 Winter Park Home to World 26apos 3Bs Foremost Producers of Large Scale Decontamination Equipment 13379 1 Winter Park Home to World 26apos 3Bs Foremost Producers of Large Scale Decontamination Equipment 13379 2 Germgards New Room Temperature Surgical Instrument Sterilizer Achieves Total Cycle Time of Three Minutes 53704 1 Germgards New Room Temperature Surgical Instrument Sterilizer Achieves Total Cycle Time of Three Minutes 53704 2 Germgards New Room Temperature Surgical Instrument Sterilizer Achieves Total Cycle Time of Three Minutes 53704 3

[0] Reportlinker Adds Chiral Technology - International Technology & Market Trends [0] Reportlinker Adds Hepatitis C Virus and Therapeutics - A Global Update of Market Trends & Opportunities [0] Fountain Healthy Aging Inc Business Update For Shareholders

...poprotein Lipase,Deficiency Established , Amsterda...cular,Therapeutics (AMT), a leader in the field of...clinical trial results with its lead,product AMT-0...otein Lipase (LPL) deficient patients at the 10th ...rapy (ASGT) in Seattle.,The study,s lead investiga...

...all/ -- Lev,Pharmaceuticals, Inc. ("Lev" or the "C...ient treatment in the prophylactic portion of,its ...(C1-INH) for,hereditary angioedema (HAE). The clin...ted the efficacy and safety of C1-INH,replacement ...ylactic treatment to prevent HAE attacks. , Lev pr...

Other Medicine Technology:AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 2 AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 3 AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 4 Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 2 Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 3 Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 4

AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema

Bandeau Bra

Compression Bra

...est is a clinical chemistry assay that detects Isc... cobalt binding capacity of albumin in a patient s...IMA is produced when circulating albumin comes in ...ischemia, the N-terminus of albumin is altered thr...

Osteomark NTx EIA - Serum

Medicine Products:

Bandeau Bra Compression Bra IMA ACB Test COBAS Mira Plus, 100T Osteomark NTx EIA - Serum

( A new genetic discovery could help give...)Progesterone Found To Increase Ovarian Cancer Risk,Health